Form 8-K - Current report:
SEC Accession No. 0001193125-25-007077
Filing Date
2025-01-15
Accepted
2025-01-15 16:39:57
Documents
14
Period of Report
2025-01-15
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d900097d8k.htm   iXBRL 8-K 36920
2 EX-3.1 d900097dex31.htm EX-3.1 10664
  Complete submission text file 0001193125-25-007077.txt   184020

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alvr-20250115.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20250115_lab.xml EX-101.LAB 19483
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20250115_pre.xml EX-101.PRE 12154
17 EXTRACTED XBRL INSTANCE DOCUMENT d900097d8k_htm.xml XML 4010
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

EIN.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 25533385
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)